ChromaDex Corp. (CDXC) is Issued First Patent for Pterostilbene, the Powerful, Innovative Ingredient in its BluScience™ Line of Dietary Products
ChromaDex, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic, and pharmaceutical industries, has been awarded patent #8,133,917 from the U.S. Patent and Trademark Office. This patent concerns the ingredient pterostilbene, which is licensed exclusively to ChromaDex; it is also the first ChromaDex-licensed patent issued for pterostilbene, while several more patents are pending. The three primary components in this patent, which encompasses the pharmaceuticals market as well as the nutraceutical market, pertain to: 1. A method of lowering lipid levels and to treat or reduce the risk of dyslipidemias…